Covered recipient · General Payments record
PATRICK STEVENS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$738.96
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.88 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $54.14 | 3 |
| Amgen Inc. | $50.58 | 3 |
| Acerta Pharma LLC | $44.38 | 3 |
| Gilead Sciences, Inc. | $27.51 | 1 |
| GlaxoSmithKline, LLC. | $22.65 | 1 |
| SHIELD THERAPEUTICS INC | $17.10 | 1 |
| PFIZER INC. | $13.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.08 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692986 | CMS |
| Amgen Inc. | $16.29 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692988 | CMS |
| Amgen Inc. | $19.21 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117692990 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.44 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105646188 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.61 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104613242 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.33 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105480255 | CMS |
| Gilead Sciences, Inc. | $27.51 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133633708 | CMS |
| GlaxoSmithKline, LLC. | $22.65 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116115872 | CMS |
| Novo Nordisk Inc | $20.04 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097762019 | CMS |
| Novo Nordisk Inc | $16.23 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096811473 | CMS |
| Novo Nordisk Inc | $17.87 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097104126 | CMS |
| PFIZER INC. | $13.52 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132062184 | CMS |
| SHIELD THERAPEUTICS INC | $17.10 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150116941 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.